The study looked at more than 53 million singleton births that occurred in the 50 most populous cities in the U.S. during the ...

Almost a dozen pharmaceutical companies have lost sensitive customer data due to a supply chain cyberattack that trickled ...

As scientists celebrate gene therapy's ability to enable hearing, deaf people are feeling a familiar dread: Are we endangered ...

Seeking to build up its pharma business, the Japanese conglomerate Asahi Kasei is moving to buy Calliditas Therapeutics in a ...

Get a preview of STAT's coverage for #ASCO2024, from events to a pop-up newsletter to the buzziest abstracts that will be ...

An Insmed drug successfully reduced flare-ups of lung problems among patients with an airway disease in a closely watched ...

Agios Pharmaceuticals announced a $905 million purchase with Royalty Pharma —Pheon Therapeutics raised a $120 million Series ...

A new dark money group called “Defend our DNA” has started to run some social media ads supporting the BIOSECURE Act.

Japanese drugmaker Nippon Shinyaku said that its Duchenne muscular dystrophy drug, Viltepso, had failed to reach its primary ...

STAT culled through 5,000 abstracts of cancer studies being published at ASCO 2024 and highlights those that look to be ...

At the height of the Covid-19 pandemic, 25 heads of government issued an extraordinary call for a new international treaty ...

How easy is it to switch from seasonal to pandemic flu vaccine production? Does a bird flu vaccine for cows make sense? The ...